News
ONVO
1.540
+1.32%
0.020
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/24 13:06
Organovo Announces Target Validation Ahead Of Schedule, Accelerating Timeline For First Crohn's Disease Drug Candidates
Benzinga · 11/15 13:17
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Benzinga · 09/22 10:34
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.
Benzinga · 09/16 10:35
UiPath, Frontline, FLEX LNG among premarket losers' pack
Shuttle Pharmaceuticals Holdings (SHPH) -22%. UiPa...
Seekingalpha · 09/07 12:29
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 09/07 12:21
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Benzinga · 09/07 09:16
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Benzinga · 09/06 17:36
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease, today announced that Keith Mur...
GlobeNewswire · 09/06 12:20
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 09/06 12:15
Organovo Announces Postponement of Annual Meeting of Stockholders
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease (the “Company”), today announce...
GlobeNewswire · 09/06 12:05
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Benzinga · 09/06 10:41
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 07/11 12:37
ONVO, FFIE and MYMD among pre market gainers
Seritage Growth Properties (SRG) +52%<a href="https://seekingalpha.com...
Seekingalpha · 07/08 12:28
We're Not Very Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Simply Wall St. · 07/08 12:05
Inovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leave
FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma
Seekingalpha · 06/06 15:59
Organovo Says Co Achieves 3D Tissue Model For Crohn's Disease
Organovo Holdings, Inc. (NASDAQ:ONVO), a three-dimensional (3D) biology company focused on delivering scientific and medical breakthroughs using novel technologies including 3D bioprinting, today announces that it has
Benzinga · 05/17 12:12
Organovo Holdings to Proceed With Target Discovery, Validation for Crohn's Disease After Achieving 3D Tissue Model
MT Newswires · 05/17 11:46
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they have reached agreement on a broad license for BICO and its affiliate companies to Organovo’s foundationa...
GlobeNewswire · 03/01 13:05
More
Webull provides a variety of real-time ONVO stock news. You can receive the latest news about Organovo Holding through multiple platforms. This information may help you make smarter investment decisions.
About ONVO
Organovo Holdings, Inc. is an early stage biotechnology company that focuses on building high fidelity, three-dimensional (3D) tissues that recapitulate various aspects of human disease. The Company uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. It is initially focusing on the intestine and has ongoing 3D tissue development efforts in ulcerative colitis (UC) and Crohns disease (CD). It uses its technology to build functional 3D human tissues that mimic various aspects of native human tissue composition, architecture, function, and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Its 3D human tissue platform is multifaceted.